Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 226

1.

The expression of type III hyperlipoproteinemia: involvement of lipolysis genes.

Henneman P, van der Sman-de Beer F, Moghaddam PH, Huijts P, Stalenhoef AF, Kastelein JJ, van Duijn CM, Havekes LM, Frants RR, van Dijk KW, Smelt AH.

Eur J Hum Genet. 2009 May;17(5):620-8. doi: 10.1038/ejhg.2008.202. Epub 2008 Nov 26.

2.

Unraveling hyperlipidemia type III (dysbetalipoproteinemia), slowly.

Schaefer JR.

Eur J Hum Genet. 2009 May;17(5):541-2. doi: 10.1038/ejhg.2008.222. Epub 2008 Nov 26. No abstract available.

3.

Polymorphisms in the apolipoprotein A5 (APOA5) gene and type III hyperlipidemia.

Evans D, Seedorf U, Beil FU.

Clin Genet. 2005 Oct;68(4):369-72.

PMID:
16143024
4.
5.

Cerebrovascular atherosclerosis in type III hyperlipidemia is modulated by variation in the apolipoprotein A5 gene.

Evans D, Bode A, von der Lippe G, Beil FU, Mann WA.

Eur J Med Res. 2011 Feb 24;16(2):79-84.

6.
7.

Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia.

Smith RC, Segman RH, Golcer-Dubner T, Pavlov V, Lerer B.

Pharmacogenomics J. 2008 Jun;8(3):228-36. Epub 2007 Aug 28.

PMID:
17726453
8.

The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study.

Martinelli N, Trabetti E, Bassi A, Girelli D, Friso S, Pizzolo F, Sandri M, Malerba G, Pignatti PF, Corrocher R, Olivieri O.

Atherosclerosis. 2007 Apr;191(2):409-17. Epub 2006 May 8.

PMID:
16682041
9.

Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-study.

Ariza MJ, Sánchez-Chaparro MA, Barón FJ, Hornos AM, Calvo-Bonacho E, Rioja J, Valdivielso P, Gelpi JA, González-Santos P.

BMC Med Genet. 2010 Apr 29;11:66. doi: 10.1186/1471-2350-11-66.

10.

Strong linkage disequilibrium and association of -1131T>C and c.553G>T polymorphisms of the apolipoprotein A5 gene with hypertriglyceridemia in a Japanese population.

Matsunaga A, Arishima H, Niimura H, Zhang B, Uehara Y, Ohwaki K, Morita M, Hayashida K, Saku K.

Circ J. 2007 May;71(5):746-52.

11.

Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome.

Niculescu LS, Vlădică M, Sima AV.

Biochem Biophys Res Commun. 2010 Jan 1;391(1):587-91. doi: 10.1016/j.bbrc.2009.11.103. Epub 2009 Nov 20.

PMID:
19932084
12.

A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemia.

Hegele RA, Ban MR, Hsueh N, Kennedy BA, Cao H, Zou GY, Anand S, Yusuf S, Huff MW, Wang J.

Hum Mol Genet. 2009 Nov 1;18(21):4189-94. doi: 10.1093/hmg/ddp361. Epub 2009 Aug 5.

13.

Rare variants in the lipoprotein lipase (LPL) gene are common in hypertriglyceridemia but rare in Type III hyperlipidemia.

Evans D, Arzer J, Aberle J, Beil FU.

Atherosclerosis. 2011 Feb;214(2):386-90. doi: 10.1016/j.atherosclerosis.2010.11.026. Epub 2010 Nov 26.

PMID:
21159338
15.
16.

Severe hyperlipidemia in apolipoprotein E2 homozygotes due to a combined effect of hyperinsulinemia and an SstI polymorphism.

Sijbrands EJ, Hoffer MJ, Meinders AE, Havekes LM, Frants RR, Smelt AH, De Knijff P.

Arterioscler Thromb Vasc Biol. 1999 Nov;19(11):2722-9.

PMID:
10559017
17.

Association of apolipoprotein A-V concentration with apolipoprotein A5 gene -1131T>C polymorphism and fasting triglyceride levels.

Kim JY, Kim OY, Paik JK, Lee SH, Lee JH.

J Clin Lipidol. 2013 Mar-Apr;7(2):94-101. doi: 10.1016/j.jacl.2012.06.002. Epub 2012 Jun 28.

PMID:
23415427
18.

Modulation of phenotypic expression of APOA5 Q97X and L242P mutations.

Charrière S, Cugnet C, Guitard M, Bernard S, Groisne L, Charcosset M, Pruneta-Deloche V, Merlin M, Billon S, Delay M, Sassolas A, Moulin P, Marçais C.

Atherosclerosis. 2009 Nov;207(1):150-6. doi: 10.1016/j.atherosclerosis.2009.04.021. Epub 2009 Apr 24.

PMID:
19447388
19.

Prevalence of alleles encoding defective lipoprotein lipase in hypertriglyceridemic patients of French Canadian descent.

Minnich A, Kessling A, Roy M, Giry C, DeLangavant G, Lavigne J, Lussier-Cacan S, Davignon J.

J Lipid Res. 1995 Jan;36(1):117-24.

20.

APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemia.

Wang J, Ban MR, Kennedy BA, Anand S, Yusuf S, Huff MW, Pollex RL, Hegele RA.

Nat Clin Pract Cardiovasc Med. 2008 Nov;5(11):730-7. doi: 10.1038/ncpcardio1326. Epub 2008 Sep 9.

PMID:
18779834

Supplemental Content

Support Center